mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.02 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.02 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.02 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.02 |
mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.02 |
mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.02 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.02 |